F. Cardenal

942 total citations
21 papers, 696 citations indexed

About

F. Cardenal is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, F. Cardenal has authored 21 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in F. Cardenal's work include Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer therapeutics and mechanisms (5 papers). F. Cardenal is often cited by papers focused on Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer therapeutics and mechanisms (5 papers). F. Cardenal collaborates with scholars based in Spain, United States and United Kingdom. F. Cardenal's co-authors include Rafael Rosell, Núria Viñolas, Núria Malats, Francisco X. Real, J. B. Posner, Francesc Graus, Javier García del Muro, Catalina Vadell, R. Reñé and Jan J.G.M. Verschuuren and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

F. Cardenal

21 papers receiving 675 citations

Peers

F. Cardenal
Nagaaki Katoh Japan
Nicholas Murray United Kingdom
Kevin C. De Braganca United States
Takaomi Koga Japan
Charlotte Westbury United Kingdom
Marc Barritault France
D Beck Switzerland
Angela J. Sievert United States
Robin Wachowiak Germany
Jinchun Yan United States
Nagaaki Katoh Japan
F. Cardenal
Citations per year, relative to F. Cardenal F. Cardenal (= 1×) peers Nagaaki Katoh

Countries citing papers authored by F. Cardenal

Since Specialization
Citations

This map shows the geographic impact of F. Cardenal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cardenal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cardenal more than expected).

Fields of papers citing papers by F. Cardenal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Cardenal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cardenal. The network helps show where F. Cardenal may publish in the future.

Co-authorship network of co-authors of F. Cardenal

This figure shows the co-authorship network connecting the top 25 collaborators of F. Cardenal. A scholar is included among the top collaborators of F. Cardenal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Cardenal. F. Cardenal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Fábio, Corinne Faivre‐Finn, Fabiola Fernández‐Gutiérrez, et al.. (2017). Use of G-CSF and prophylactic antibiotics with concurrent chemo-radiotherapy in limited-stage small cell lung cancer: Results from the Phase III CONVERT trial. Annals of Oncology. 28. ii61–ii61. 4 indexed citations
2.
Simó, Marta, Xavier Rifà‐Ros, Lucía Vaquero, et al.. (2017). Brain functional connectivity in lung cancer population: an exploratory study. Brain Imaging and Behavior. 12(2). 369–382. 31 indexed citations
3.
Cardenal, F., Ernest Nadal, Maria Jové, & Corinne Faivre‐Finn. (2014). Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature. Annals of Oncology. 26(2). 278–288. 25 indexed citations
4.
Provencio, Mariano, Carlos Camps, Manuel Cobo, et al.. (2012). Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer. Cancer Chemotherapy and Pharmacology. 70(6). 883–890. 17 indexed citations
5.
Viñolas, Núria, Mariano Provencio, Noemı́ Reguart, et al.. (2010). Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. Lung Cancer. 71(2). 191–198. 39 indexed citations
6.
7.
8.
Karp, Daniel D., F. Cardenal, Paul Haluska, et al.. (2009). Continued high activity of figitumumab (CP-751,871) combination therapy in squamous lung cancer. Journal of Clinical Oncology. 27(15_suppl). 8072–8072. 10 indexed citations
9.
Reguart, Noemı́, Andrés F. Cardona, Dolores Isla, et al.. (2009). Phase I trial of vorinostat in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations after erlotinib progression. Journal of Clinical Oncology. 27(15_suppl). e19057–e19057. 3 indexed citations
10.
11.
Mesı́a, Ricard, Margarita Majem, M.P. Barretina Ginesta, et al.. (2007). Treatment of patients with unresectable squamous head and neck cancer with induction chemotherapy followed by hyperfractionated radiotherapy. Cancer/Radiothérapie. 12(2). 88–95. 2 indexed citations
12.
Scagliotti, Giorgio V., Aleksandra Szczęsna, Rodryg Ramlau, et al.. (2006). Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer. British Journal of Cancer. 94(10). 1375–1382. 25 indexed citations
13.
Senan, Suresh, F. Cardenal, Jos A. Stigt, et al.. (2006). 159. International Journal of Radiation Oncology*Biology*Physics. 66(3). S89–S90. 2 indexed citations
14.
15.
Gatzemeier, U., J P Kleisbauer, P. Drings, et al.. (2000). Lenograstim as Support for ACE Chemotherapy of Small-Cell Lung Cancer. American Journal of Clinical Oncology. 23(4). 393–400. 25 indexed citations
16.
Dómine, Manuel, F. Cardenal, Bartomeu Massutí, et al.. (2000). Phase II study of an intensive single dose of irinotecan (CPT-11) and cisplatin (CDDP) every three weeks, in patients with advanced non-small cell lung cancer. Lung Cancer. 29(1). 55–55. 2 indexed citations
17.
Rosenfeld, Myrna R., Laura Schramm, J. B. Posner, et al.. (1997). Serum Anti-p53 Antibodies and Prognosis of Patients With Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 89(5). 381–384. 45 indexed citations
18.
Graus, Francesc, R. Reñé, Núria Malats, et al.. (1997). Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.. Journal of Clinical Oncology. 15(8). 2866–2872. 300 indexed citations
19.
Vicente, Pilar, et al.. (1995). [Spontaneous pneumothorax in response to chemotherapy of metastatic germinal tumor].. PubMed. 12(6). 307–8. 1 indexed citations
20.
Cardenal, F., et al.. (1979). [Superior vena cava syndrome due to tuberculous mediastinal fibrosis. Report of two cases (author's transl)].. PubMed. 73(3). 103–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagaaki Katoh Breakdown of academic impact, for papers by Nicholas Murray Breakdown of academic impact, for papers by Kevin C. De Braganca Breakdown of academic impact, for papers by Takaomi Koga Breakdown of academic impact, for papers by Charlotte Westbury Breakdown of academic impact, for papers by Marc Barritault Breakdown of academic impact, for papers by D Beck Breakdown of academic impact, for papers by Angela J. Sievert Breakdown of academic impact, for papers by Robin Wachowiak Breakdown of academic impact, for papers by Jinchun Yan
Rankless by CCL
2026